SAT0113 Implementation of The Treat-To-Target Strategy Leads To Dramatically Reduction of N-Terminal Pro-Brain Natriuretic Peptide Level in Patients with Early Rheumatoid Arthritis

Abstract

Objectivesto study the effect of antirheumatic therapy administered in accordance with “treat-to-target” principles on NT-proBNP level in early rheumatoid arthritis (RA) patients (pts) during 18-month follow-upMethodsA total of 66 early...